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Abstract The self-assembling of double-stranded DNA with
short synthetic peptides has been analysed using the fluorescent
properties of the intercalating dye, ethidium bromide. Two
membrane-active peptides with appropriate sequences of lysine
and leucine amino acids and a short polylysine have been probed.
The results revealed that the secondary structure of the peptide
decisively aimed the peptide-DNA complex formation: only the
longest peptide, which is the only one to exhibit an K-helical
structure in solution, could achieve DNA compacting before
charge neutralisation. The obtained complex retained a sig-
nificant membrane activity as demonstrated by calcein leakage
experiments. This shows that short synthetic peptides of
elementary sequence can combine both membrane activity and
DNA-condensing properties. The potential of these constructs as
DNA carriers will be discussed.
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1. Introduction
Active research in the ¢eld of drug delivery and gene ther-
apy has demonstrated the importance of creating discrete mo-
lecular assembling of DNA with condensing agents to trans-
fect cells. The DNA-condensing e¡ects of a number of
polycations and cationic proteins such as polylysine, spermine
or histones have been well known for decades (e.g. [1^4]) and
collection of polycation-based vectors for gene transfer has
been tested (e.g. [5^11]). While almost all of them were able
to collapse DNA around the charge neutralisation point, un-
equal results were obtained with the transfection e⁄ciency [7].
Moreover, the ability of polycation-DNA complexes to trans-
fect cells appeared to be highly dependent on the presence of
lysosomotropic e¡ectors such as chloroquine which partially
bypass the lysosomal degradation of DNA [12^14]. To ¢nd a
rational and controlled way to escape the endosome now ap-
pears to be the next step forward in the elaboration of nucleic
acid carriers. An attractive idea consists in incorporating a
membrane-active compound, such as a peptide, in the carrier
construction and several groups have already begun to test
this concept in transfection experiments [14^18]. However,
the achievement of this approach requires the identi¢cation
and the understanding of the key parameters that govern
the DNA-peptide self-assembling structures and their activity.
In this paper, we investigated the ability of short synthetic
amphipathic peptides, already known for their membrane ac-
tivity [19], to condense DNA, envisaging the possibility for the
complex to evade the lysosomes owing to the peptide mem-
brane activity. We examined model peptides constructed on
the basis of only two di¡erent amino acids, a hydrophilic one
bearing a positive charge, lysine (K), and a hydrophobic one,
leucine (L). The sequence was chosen to provide ideal parallel
amphipathy along the helix. A 9-residue (KLLLKLLLK) and
a 15-residue (KLLKLLLKLLLKLLK) peptide were studied
together with a short 4^5-residue polylysine.
2. Materials and methods
2.1. Materials
The two peptides, H3N-Lys-Leu-Leu-Leu-Lys-Leu-Leu-Leu-Lys-
COO3 (LK9) and H3N-Lys-Leu-Leu-Lys-Leu-Leu-Leu-Lys-Leu-
Leu-Leu-Lys-Leu-Leu-Lys-COO3 (LK15) were synthesised by Neo-
system (Strasbourg, France) and were more than 95% pure. Stock
solutions were prepared in methanol. Further dilution was done in
a water:methanol (5:1) mixture. The short polylysine (PLL), 4^5 res-
idues long, was from Sigma. Calf thymus double-stranded DNA was
purchased from Sigma and precipitated in ethanol solution. Ethidium
bromide (EtBr) was from Molecular Probes. All experiments were
performed in 30 mM Tris bu¡er added with 120 mM NaCl. Egg
yolk phosphatidylcholine (EPC) was puri¢ed according to Singleton
et al. [20].
2.2. Vesicle preparation
Large unilamellar vesicles (LUV) were prepared by freezing-thaw-
ing of a swollen phospholipid ¢lm followed by extrusion through a
200 nm calibrated polycarbonate ¢lter as previously described by
Mayer et al. [21] except the ¢lm was hydrated with a 4U1034 M
calcein solution instead of bu¡er. Untrapped calcein was removed
by passing the vesicles over an AcA 54 Ultrogel column, equilibrated
with Tris-NaCl bu¡er. Phospholipid concentration in the eluted
vesicle fraction was measured by titration of inorganic phosphate
[22] and adjusted to 5 mM in the stock suspension.
2.3. Fluorescence measurements
Double-stranded calf thymus DNA condensation was analysed us-
ing EtBr £uorescence properties. When the helix is in random coil
state, the dye intercalates between the DNA base pairs and the £uo-
rescence intensity of the dye increases signi¢cantly (reviewed by Le
Pecq [23]). Upon condensation of the helix the intercalated dye is
excluded from DNA resulting in a decrease in £uorescence intensity.
Measurements were performed with a Spex Fluoromax spectrometer
equipped with a thermostatted cuvette holder maintained at 25‡C for
all experiments. Excitation wavelength was set at 510 nm where
DNA-bound and free forms of EtBr have the same molar extinction
coe⁄cient. A 4 nm band pass was used. The spectra, recorded from
525 to 700 nm, made it possible to measure the maximum £uorescence
intensity of the dye located around 595 nm (I595) and the intensity of
the right Raleigh line bottom scattered at 525 nm (I525). The £uores-
cence intensity obtained in the presence of the condensing agent (I595)
was normalised to the intensity measured in its absence on the same
sample (Io595) and called t= Io595/I595.
Calcein leakage from EPC vesicles was determined by adding 50
mM CoCl2 in the vesicle suspension to quench external calcein £uo-
rescence [24]. Dye release kinetics were monitored at 515 nm, the
excitation wavelength was set at 490 nm.
2.4. Circular dichroism
The spectra were recorded with a dichrograph Mark V from Jobin
Yvon (Longjumeau, France).
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3. Results and discussion
A marked increase in the £uorescence intensity of the het-
erocyclic dye EtBr occurs upon double-stranded DNA bind-
ing, depending on the topological constraints of the DNA
tertiary structure [23]. This property was used here to probe
the interactions of short cationic peptides with double-
stranded DNA in so far as these interactions will change the
DNA topology. Fig. 1 shows the £uorescence spectra of EtBr
either free or bound to the DNA helix together with the
spectra obtained with increasing concentrations of LK15.
The peptide obviously induced a signi¢cant decrease of the
£uorescence of the intercalated dye. Interestingly, the intensity
of scattered light increased in a closely correlated way as in-
dicated by the presence of an isosbestic point in the wave-
length region where £uorescence and scattering overlap (we
checked, using an inert emulsion as a scattering source, that in
our conditions the light scattered in the Raleigh region did not
a¡ect the £uorescence spectra). Fig. 2 shows the changes of
the relative £uorescence intensity t and of the Raleigh scatter-
ing intensity at 525 nm for labelled DNA compelled with
increasing concentrations of LK15, LK9 or PLL, the short
polylysine of 4^5 lysine residues. At the pH of the experi-
ments, LK15 and LK9 have 5 and 3 positive charges per
molecule, respectively. The data are presented as a function
of the concentration of positive charges produced by each
peptide, knowing that the DNA concentration corresponded
to 1035 M in phosphate, i.e. in negative charges. In each case,
the £uorescence decreased to a plateau level which corre-
sponded to a relative £uorescence value, tp, equal to
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Fig. 2. Fluorescence and light scattering of EtBr intercalated in 1035 M DNA (phosphate concentration) with increasing concentrations of pep-
tides added. The £uorescence intensity was measured at 595 nm (upper panels) and light scattering at 525 nm (lower panels). The dashed lines
indicate the neutralisation points. [n+)] represents the concentration of positive charges brought by each peptide, knowing that LK15, PLL and
LK9 bear 5, 4^5 and 3 positive charges, respectively.
Fig. 1. Ethidium bromide £uorescence spectra. A: EtBr 7U1038 M in the absence and in the presence of 6U1035 M DNA. B: EtBr interca-
lated in 6U1035 M DNA recorded in the presence of increasing concentrations of LK15. In 20 mM Tris bu¡er, 130 mM NaCl. Excitation
wavelength was set at 510 nm.
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0.35 þ 0.05. The scattering evolved in a closely correlated way.
Other characteristics of the interaction di¡ered greatly be-
tween LK15 on the one hand and LK9 and PLL on the other
hand. With LK15, the signal showed a steep decrease from the
lowest peptide concentrations to a plateau which arose around
the charge neutralisation, i.e. one positive charge brought by
the peptide for one DNA phosphate. The scattering increased
correspondingly as the £uorescence decreased. In contrast, in
the case of LK9 and PLL, the £uorescence signal remained
unchanged until the peptide concentration reached the DNA
charge neutralisation ratio. The scattering increase appeared
to be slightly shifted towards the highest concentrations as
compared to the £uorescence increase. The £uorescence and
scattering plateaus were both obtained for peptide concentra-
tions equal to 5U1035 M, i.e. for a positive to negative charge
ratio close to 5, far above the neutralisation point.
Clearly, the three peptides studied here were able to cause a
drop of the intercalated dye £uorescence. The pro¢les of rel-
ative £uorescence decrease were not in£uenced when EtBr
concentration was changed showing that the probe did not
a¡ect the reported process. However, the number of EtBr
per base pair was always kept below 1/30. The £uorescence
drop was interpreted as a release of the dye from the double
helix into the bu¡er, although a quantum yield decrease due
to a change in the structure of the intercalation complex could
not entirely be excluded. Nevertheless, whatever the actual
molecular mechanism of the £uorescence decrease, it neces-
sarily implies that a change in DNA structure has occurred.
The rate of EtBr intercalation mostly depend on topological
constraints: for instance negative supercoilings disfavoured
intercalation by reducing the possibility of the helix to relax
by lengthening [23]. The pro¢les obtained with LK9 and PLL
exhibited a cooperative shape strongly suggesting that the
DNA had undergone a conformational transition from the
initial random coil state to a condensed phase. This coopera-
tivity has been previously observed with a collection of cati-
onic entities (e.g. [1,25^27]) and analysed within the frame-
work of the counterion condensation theory developed by
Manning for polyelectrolytes [28]. This theory predicts that
back and forth folding of the helix on itself occurs when the
linear charge density of the phosphate backbone has been
lowered enough by neutralising above 90% of the DNA neg-
ative charges in physiologic ionic strength. The simultaneous
increase of light scattering intensity suggests the formation of
discrete insoluble entities in agreement with the condensation
hypothesis. However, these data do not allow a distinction
between mono-molecular or inter-molecular condensates,
only the shift in concentration of the scattering pro¢le com-
pared to the £uorescence could lend support to the idea that
inter-molecular condensation has taken place. Therefore, the
two peptides LK9 and PLL appeared to act only as polyca-
tionic entities which neutralise the DNA backbone and in-
duce, in this way, cooperative condensation. The situation is
di¡erent with LK15, where both £uorescence and scattering
turned at a peptide concentration as low as 5U1038 M, i.e. a
low positive to negative charge ratio (r þ ) equal to 0.025. This
peptide was then much more e⁄cient in DNA condensation
than the LK9 analogue or the short polylysine which held the
same charge number. Surprisingly, the e¡ect on DNA exerted
by this peptide did not require charge neutralisation. It also
possibly led to a di¡erent complex type.
In order to ¢nd some clue to explain the behaviour of
LK15, we performed circular dichroism (CD) measurements
to investigate the secondary structure of the peptides. CD
recordings presented in Fig. 3 clearly show that LK15 was
the only one whose spectrum exhibited the characteristic fea-
tures of an K-helical structure, i.e. strong negative bands lo-
cated at 207 and 222 nm [29]. The same di¡erential absorp-
tion, vO, was observed between 1036 and 2U1035 M peptide,
indicating that in this concentration range no structural
changes occurred. LK9 showed only a very low level of struc-
turing and none was found with PLL (Fig. 3). In the presence
of DNA (data not shown), the spectra were largely dominated
by DNA helix signal and did not bring any information on
the structure of the peptides within the complex. Together
with the £uorescence results, the CD data strongly suggest
that the secondary structure of the peptide, opposing polar
and apolar faces, plays a central role in its interaction with
DNA. Indeed, LK15 presents to interact with DNA not only
an ordered array of lysine residues but also a de¢ned hydro-
phobic domain which is expected to support self-association
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Fig. 4. Calcein leakage from EPC LUVs. The rate constant, k (a)
and the amplitude of the decay, A (b), are given as a function of
DNA (phosphate) concentration. The insert shows two representa-
tive adjustments (lines) of the data (points) according to a mono-ex-
ponential decay. [EPC] = 5U1036 M.
Fig. 3. Circular dichroism spectra of the three peptides LK15, LK9
and PLL, 1035 M in 20 mM Tris, 130 mM NaCl. Background, re-
corded with the bu¡er alone, was subtracted in each case.
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of the peptides with each other. This self-association has al-
ready been observed in solution (Castano et al., personal com-
munication) and could very likely be responsible for the dis-
tinct interaction observed between LK15 and DNA. In this
hypothesis, the self-association of the peptides would create
knots within the complexes inducing the topological con-
straints responsible for the dye exclusion. Being di¡erent in
nature, this interaction would not require previous neutralisa-
tion of the DNA helix to settle but could occur locally at the
lowest concentrations. Additional experiments are in progress
to explore this hypothesis. Up to now, most reported DNA
condensation required quasi-total neutralisation of the DNA
backbone by the condensing agent. Wyman et al. [18] have
worked with membrane-active peptides which acquired an K-
helical structure at pHs higher than 7 but did not report any
in£uence of the secondary structure on the characteristics of
the interaction with nucleic acids. Emile et al. [30] noticed a
better ability of K-helix structures to bind oligonucleotides as
compared to L-sheets; however, this was attributed in their
paper to a more adapted geometry of the lysine groups and
not to any hydrophobic e¡ect. Also worthy of mention is the
fact that, independently of their ability to bind DNA, several
peptides holding a well de¢ned secondary structure have been
shown to achieve e⁄cient transfer of nucleic acids in cells
[14,31^33].
As previous experiments had clearly shown that LK15 was
able to form a complex with DNA at low concentrations, we
were, at this point, interested in determining how the associ-
ation of the peptide with DNA a¡ected the membrane activity
of the peptide. This activity was evaluated by measuring cal-
cein leakage from EPC LUVs. The kinetic pro¢les obtained
either with LK15 alone or with LK15 bound to DNA within
the complex showed that increasing the concentration of
DNA, i.e. the degree of peptide association, slowed down
the leakage and reduced its ¢nal amplitude. The kinetics sat-
isfyingly ¢tted a mono-exponential decay of the form F(t) = A
exp(3kt)+Fo, where A and k are the amplitude of the leakage
and its apparent rate constant, respectively. Fo stands for the
£uorescence background remaining after complete release of
the dye. A and k were determined by parameter adjustment.
The rate constant k decreased from 5U1032 s31 (value ob-
tained with the peptide alone) to a plateau value close to 1032
s31 (Fig. 4a) obtained for a DNA concentration near 1036 M,
i.e. around the charge neutralisation, identi¢ed above as the
point where the complex formation was achieved. The relative
amplitude of the leakage (Fig. 4b) remained equal to 1 which
corresponds to total release of the dye, up to 4U1037 M
DNA; then the amplitude dropped steeply to reach a plateau
value near 0.5 for DNA concentrations higher than 1036 M.
This lends support to the idea that in a ¢rst step ^ DNA
concentration lower than 1036 M ^ the release of the dye
was induced by free peptide which remained uncomplexed at
these DNA concentrations. The leakage is then total (A = 1)
and the rate constant of the leakage depends on the free pep-
tide concentration continuously decreasing as DNA increases.
Then, when the DNA concentration exceeds 1036 M, corre-
sponding to the charge neutralisation point, the process was
no more driven by free peptide, which then had a negligible
concentration, but rather by the DNA-peptide complex whose
activity was characterised by a rate constant value equal to
1032 s31 and a leakage amplitude equal to 0.5. This actually
attests to a membrane activity of the complex itself. This
di¡ers from the results obtained by Wyman et al. [18] where
a DNA excess totally suppressed the membrane activity of the
peptide they used.
4. Conclusion
We have shown above that (i) the K-helix represents an
exquisite structural motif for the interaction of peptides with
DNA. The interaction appeared to be driven at ¢rst by elec-
trostatic interactions but most signi¢cant was the fact that the
K-helical amphipathic structure allowed topological changes
to occur in DNA much before the charge neutralisation point
in contrast with other polycationic compounds. (ii) Such com-
plexes acquired a colloidal character as shown by the increase
in light scattering, although we cannot at this point state
whether we have only a DNA mono-molecular condensation
or a multimeric aggregation. (iii) Model experiments have
shown that the peptide conserved membrane activity within
the complex even though the actual activity of the assembling
was reduced.
This work constitutes a ¢rst step in the elaboration of active
peptide-DNA molecular assembling based on short synthetic
peptides. A further step would be to extend our conclusions to
peptides conceived to retain the K-helicity and polycationic
nature but having additionally a pH sensitivity allowing these
properties to befall or not at acidic pH. This would target the
activity to the endosome speci¢cally. Another choice would be
to entrap the complexes in a colloidal system to add a level of
control of the complex’s properties like cell surface adhesion
then internalisation, or release kinetics.
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